Hamlet Pharma AB
SE0015661145 · Outside a trading venue
2 directors and managers of Hamlet Pharma AB have disclosed 2 transactions under MAR Article 19: 1 buy worth €28k and 1 sell worth €28k, which reads as net buying. The most recent disclosed transaction was on 2023-05-26. The largest buy was Linnane Pharma AB (Chief Executive Officer (CEO)/Managing Directory) for €28k. See live cluster buys or start a free 14-day trial to get alerts when Hamlet Pharma AB insiders trade.
Insiders
2
Net flow
€0
Bought
€28k
Sold
€28k
Buy Hamlet Pharma AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2023-05-26 3y ago | BUY | Linnane Pharma AB Chief Executive Officer (CEO)/Managing Directory | 100,000 | €0.28 | €28k |
| 2023-04-26 3y ago | SELL | Jakob Testad Chief Executive Officer (CEO)/Managing Directory | 100,000 | €0.28 | €28k |